Synthomer plc operates as a specialty chemicals company in the United Kingdom, Germany, Italy, the Netherlands, France, Belgium, Malaysia, China, the United States, rest of Europe, rest of Asia, and internationally. More Details
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has Synthomer's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SYNT is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: SYNT's weekly volatility (3%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: SYNT exceeded the UK Chemicals industry which returned 44.1% over the past year.
Return vs Market: SYNT exceeded the UK Market which returned 22.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Synthomer's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StIs There Now An Opportunity In Synthomer plc (LON:SYNT)?
1 month ago | Simply Wall StSynthomer (LON:SYNT) Seems To Use Debt Quite Sensibly
2 months ago | Simply Wall StCalculating The Intrinsic Value Of Synthomer plc (LON:SYNT)
Is Synthomer undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SYNT (£5.3) is trading below our estimate of fair value (£5.98)
Significantly Below Fair Value: SYNT is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: SYNT is poor value based on its PE Ratio (725.7x) compared to the UK Chemicals industry average (41.9x).
PE vs Market: SYNT is poor value based on its PE Ratio (725.7x) compared to the UK market (23.5x).
Price to Earnings Growth Ratio
PEG Ratio: SYNT is poor value based on its PEG Ratio (33.9x)
Price to Book Ratio
PB vs Industry: SYNT is overvalued based on its PB Ratio (3.7x) compared to the GB Chemicals industry average (3.5x).
How is Synthomer forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SYNT's forecast earnings growth (21.4% per year) is above the savings rate (0.9%).
Earnings vs Market: SYNT's earnings (21.4% per year) are forecast to grow faster than the UK market (14.8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SYNT's revenue (5.7% per year) is forecast to grow faster than the UK market (4.8% per year).
High Growth Revenue: SYNT's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SYNT's Return on Equity is forecast to be low in 3 years time (17.7%).
How has Synthomer performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SYNT has a large one-off loss of £108.8M impacting its December 31 2020 financial results.
Growing Profit Margin: SYNT's current net profit margins (0.2%) are lower than last year (5.8%).
Past Earnings Growth Analysis
Earnings Trend: SYNT's earnings have declined by 14.5% per year over the past 5 years.
Accelerating Growth: SYNT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SYNT had negative earnings growth (-96.3%) over the past year, making it difficult to compare to the Chemicals industry average (24.9%).
Return on Equity
High ROE: SYNT's Return on Equity (-0.2%) is considered low.
How is Synthomer's financial position?
Financial Position Analysis
Short Term Liabilities: SYNT's short term assets (£635.9M) exceed its short term liabilities (£468.4M).
Long Term Liabilities: SYNT's short term assets (£635.9M) do not cover its long term liabilities (£962.6M).
Debt to Equity History and Analysis
Debt Level: SYNT's debt to equity ratio (105.7%) is considered high.
Reducing Debt: SYNT's debt to equity ratio has increased from 52.1% to 105.7% over the past 5 years.
Debt Coverage: SYNT's debt is well covered by operating cash flow (28.1%).
Interest Coverage: SYNT's interest payments on its debt are well covered by EBIT (5.9x coverage).
What is Synthomer current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SYNT's dividend (2.19%) is higher than the bottom 25% of dividend payers in the UK market (1.31%).
High Dividend: SYNT's dividend (2.19%) is low compared to the top 25% of dividend payers in the UK market (3.94%).
Stability and Growth of Payments
Stable Dividend: SYNT's dividend payments have been volatile in the past 10 years.
Growing Dividend: SYNT's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (1589.9%), SYNT's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: SYNT's dividends in 3 years are forecast to be well covered by earnings (36.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Calum MacLean (57 yo)
Mr. Calum G. MacLean has been President and Director at OMNOVA Solutions Inc. since April 1, 2020. He serves as Director at Clariant. Mr. MacLean serves as Chief Executive Officer at Synthomer Deutschland ...
CEO Compensation Analysis
Compensation vs Market: Calum's total compensation ($USD2.49M) is above average for companies of similar size in the UK market ($USD1.69M).
Compensation vs Earnings: Calum's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Experienced Management: SYNT's management team is considered experienced (2.5 years average tenure).
Experienced Board: SYNT's board of directors are considered experienced (6.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SYNT insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Synthomer plc's company bio, employee growth, exchange listings and data sources
- Name: Synthomer plc
- Ticker: SYNT
- Exchange: LSE
- Founded: 1863
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: UK£2.250b
- Shares outstanding: 424.84m
- Website: https://www.synthomer.com
Number of Employees
- Synthomer plc
- 45 Pall Mall
- Greater London
- SW1Y 5JG
- United Kingdom
Synthomer plc operates as a specialty chemicals company in the United Kingdom, Germany, Italy, the Netherlands, France, Belgium, Malaysia, China, the United States, rest of Europe, rest of Asia, and intern...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/08/01 17:31|
|End of Day Share Price||2021/07/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.